Delivery Order SPE2DB22D2009-SPE2DB25FL8YP
- Not listed
- The Defense Logistics Agency awarded a $24,444.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The pharmaceutical product being...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $48,559.96 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. This is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, issued on September 9, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place...
- The Defense Logistics Agency awarded a $36,677.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that serves as the company's primary vehicle for supplying...
- The Defense Logistics Agency awarded a $27,040.46 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick autoinjector medication, valued at $4,540.44 under a firm fixed-price contract with an ultimate completion date of September 4, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026....
- The Defense Logistics Agency awarded a $62,369.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $23,441.27 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order represents a competitive procurement for a specialty...
- The Defense Logistics Agency awarded a delivery order valued at $12,473.38 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will serve as the place of performance. This delivery order is issued...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FL8YPDelivery Order
The Defense Logistics Agency awarded a $7,888.81 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. The contract, awarded on April 24, 2025, with a completion date of April 25, 2025, represents a firm fixed-price transaction with no set-aside designation. This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical procurement through the DLA Medical Supply Chain. As the prime contractor on this delivery order, the company continues to fulfill its role supporting the Defense Health Agency and other government healthcare systems with specialty medications and medical commodities. The contract reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through competitive awards and underscores the company's significance within the military's pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 4/24/25 |